E-Cigarette Use, Cigarette Smoking, and Sex Are Associated With Nasal Microbiome Dysbiosis
Policy
Hickman (2025)
Examining Differences in Real-World Effectiveness of e-Cigarettes for Smoking Cessation by Source of Purchase in England: An Observational Study of Different Contexts Before and After the COVID-19 Pandemic
Nonclinical
Safety Effects In Animals
Repeat-dose
Cox (2025)
Shaping the Future: Proposed Bills to Regulate New and Emerging Tobacco and Nicotine Products in Latin America and the Caribbean Amidst Public Health Concerns and Industry Interests
Nonclinical
Chemical
Analysis
Severini (2025)
A Content Analysis of Nicotine Descriptors on the Front of Vape Packaging in the United Kingdom
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ford (2025)
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Azzopardi (2022)
New recreational nicotine lozenges, tablets, gummies and gum proliferate on the US market
General
Industry Information
Market Availability
Borowiecki et al. (2024)
A Novel Nicotine Sublingual Tablet which Mimics Cigarette Smoking Pharamceuticals
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McCarty (2015)
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Dautzenberg et al (2007)
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Gisleskog et al (2021)
Nicotine replacement therapy versus control for smoking cessation
Individual Clinical
All Categories
Hartmann‐Boyce et al (2025)